Form 4 Tracker
Benjamin J. Hindson

Director, Title: President and Chief Scientific Officer; Director, Title: President and Chief Scientific Officer; Exhibit 24.1 - Power of Attorney · 4 filings · Latest: Aug 24, 2026

10x Genomics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TXG
Benjamin J. HindsonDirector, Title: President and Chief Scientific OfficerAug 24, 2026
Sale
$63.0213,818$870.9K488,182
TXG
Hindson Benjamin J.—Aug 24, 2026
Proposed Sale
$65.1213,373$870.8K—
TXG
Benjamin J. HindsonDirector, Title: President and Chief Scientific OfficerMay 22, 2026
Sale
$24.4411,595$283.4K502,000
TXG
Hindson Benjamin J.—May 22, 2026
Proposed Sale
$24.689,430$232.7K—
TXG
Benjamin J. HindsonDirector, Title: President and Chief Scientific Officer; Exhibit 24.1 - Power of AttorneyFeb 23, 2026
Sale
$18.587,826$145.4K424,779
TXG
Hindson Benjamin J.—Feb 23, 2026
Proposed Sale
$19.198,301$159.3K—
TXG
Hindson Benjamin J.—Nov 24, 2025
Proposed Sale
$18.347,392$135.6K—
TXG
Hindson Benjamin J.—Aug 22, 2025
Proposed Sale
$13.417,393$99.1K—
TXG
Hindson Benjamin J.—May 22, 2025
Proposed Sale
$9.087,392$67.1K—
TXG
Hindson Benjamin J.—Feb 24, 2025
Proposed Sale
$11.564,563$52.7K—
TXG
Hindson Benjamin J.—Nov 22, 2024
Proposed Sale
$13.325,734$76.4K—
TXG
Hindson Benjamin J.—Aug 22, 2024
Proposed Sale
$23.014,351$100.1K—